{"version":"1.0","type":"link","title":"Comparison of ≥2 lines immunotherapy regimens for recurrent/metastatic nasopharyngeal carcinoma.","author_name":"Peng L 외","author_url":"https://prs-insight.online/author/Peng%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168196","thumbnail_width":1200,"thumbnail_height":630}